Management of early-stage prostate cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Managed Care

• Publication date

  2015-01-08

• Fields of study

  Medicine

• Identifiers
  PMID 25734965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

  2014cited by this paper
• Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis.

  2014cited by this paper
• Quality of Life in Patients with Low-Risk Prostate Cancer. A Comparative Retrospective Study: Brachytherapy Versus Robot-Assisted Laparoscopic Prostatectomy Versus Active Surveillance

  2014cited by this paper
• Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis

  2014cited by this paper
• Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes

  2014cited by this paper
• Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?

  2014cited by this paper
• Biomarkers in prostate cancer: what's new?

  2014cited by this paper
• Radical prostatectomy or watchful waiting in early prostate cancer.

  2014cited by this paper
• Managed Care and the Dissemination of Robotic Prostatectomy

  2014cited by this paper
• Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making.

  2014cited by this paper
• Observation Versus Initial Treatment for Men With Localized, Low-Risk Prostate Cancer

  2013cited by this paper
• Guidelines on Prostate Cancer

  2013cited by this paper
• Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis

  2013cited by this paper
• Abeloff's Clinical Oncology

  2013cited by this paper
• Divorcing Diagnosis From Treatment: Contemporary Management of Low-Risk Prostate Cancer

  2013cited by this paper
• Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy.

  2013cited by this paper
• An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee.

  2012cited by this paper
• Contemporary role of androgen deprivation therapy for prostate cancer.

  2012cited by this paper
• Why I Cannot Find the Prostate? Behind the Subjectivity of Rectal Exam

  2012cited by this paper
• Radical prostatectomy versus observation for localized prostate cancer.

  2012cited by this paper
• An economic analysis of conservative management versus active treatment for men with localized prostate cancer.

  2012cited by this paper
• Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse.

  2012cited by this paper
• Novel approaches to improve prostate cancer diagnosis and management in early‐stage disease

  2012cited by this paper
• Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high‐risk cohort of men with negative initial prostate biopsies

  2012cited by this paper
• Prostate Cancer Mortality following Active Surveillance versus Immediate Radical Prostatectomy

  2012cited by this paper
• Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007.

  2012cited by this paper
• Tumor markers in prostate cancer I: Blood-based markers

  2011cited by this paper
• Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

  2011cited by this paper
• Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

  2011cited by this paper
• Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

  2011cited by this paper
• Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

  2011cited by this paper
• Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cited by this paper
• How does initial treatment choice affect short‐term and long‐term costs for clinically localized prostate cancer?

  2010cited by this paper
• Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cited by this paper
• A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer

  2010cited by this paper
• Reimbursement policy and androgen-deprivation therapy for prostate cancer.

  2010cited by this paper
• A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer

  2010cited by this paper
• Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

  2009cited by this paper
• Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population.

  2009cited by this paper
• The harmful health effects of recreational ecstasy: a systematic review of observational evidence

  2009cited by this paper
• Current prostate cancer treatments: effect on quality of life.

  2009cited by this paper
• A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer

  2009cited by this paper
• Guideline for the management of clinically localized prostate cancer: 2007 update.

  2007cited by this paper
• Why do men choose one treatment over another?

  2006cited by this paper
• Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

  2005cited by this paper
• Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

  2004cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• EAU guidelines on prostate cancer.

  2001cited by this paper

• Missense and Intronic Variants in HNF1A Affect Prostate Cancer Aggressiveness in Patients with Biochemical Recurrence

  2026cites this paper
• Perioperative and short-term outcomes of laparoscopic radical prostatectomy in elderly patients

  2025cites this paper
• Biomarkers for Prostate Cancer Aggressiveness in Puerto Rican Men: Analysis of Phospho-Rb S249, N-cadherin, β-catenin, and E-cadherin Expression in Prostate Biopsies

  2025cites this paper
• Associations of the Expression Levels and Risk Variants of CDKN2B‐AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer

  2024cites this paper
• Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy

  2023cites this paper
• Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer

  2023cites this paper
• Bladder Outlet Obstruction: Etiological Pattern in Southwestern Nigeria

  2023cites this paper
• Prostate cancer awareness, knowledge, and perception of screening among men aged 40–70 in the Belize district

  2021cites this paper
• miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1

  2020cites this paper
• miR-138-5p inhibits the metastasis of prostate cancer by targeting FOXC1

  2020cites this paper
• A mixed-integer linear programming optimization model framework for capturing expert planning style in low dose rate prostate brachytherapy

  2019cites this paper
• Regulation of the Antioxidant Response by MyoD Transcriptional Coactivator in Castration-resistant Prostate Cancer Cells.

  2019cites this paper
• PROSTATE CANCER AWARENESS AND KNOWLEDGE; A STUDY OF ADULT MEN IN LAHORE, PAKISTAN

  2018cites this paper
• Comparative Effectiveness of Conservative Management Compared to Cryotherapy in Localized Prostate Cancer Patients

  2018cites this paper
• Elucidation of the functions of Neuropilin 2 in osteoclasts in promoting prostate cancer bone metastasis.

  2018cites this paper
• Radical prostatectomy innovation and outcomes at military and civilian institutions.

  2017cites this paper
• Nanomedicine for prostate cancer using nanoemulsion: A review

  2017cites this paper
• CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells

  2017cites this paper
• Inhibition of prostate cancer cell growth in vivo with short hairpin RNA targeting SATB1

  2017cites this paper
• Salvage image guided radiation therapy to the prostate after cryotherapy failure

  2017cites this paper
• Investigation of prostate disorders in 614 patients attended alzahra/urology ward between the years 2013 to 2015 in Isfahan

  2016cites this paper
• The level of knowledge and awareness about prostate cancer in the Turkish male and the relevant effective factors.

  2016cites this paper
• Forward to the Past-Oncology Between Underdiagnosis and Overtreatment.

  2016cites this paper
• Current Concepts and Evaluation of Uro-Rectal Diseases by Transrectal Ultrasound: A Review

  2015cites this paper